Ivan Koychev is a Consultant Neuropsychiatrist at the Oxford University Hospitals NHS Foundation Trust and a Senior Clinical Researcher at the University of Oxford. His research focuses on the development of novel treatments for the major neuropsychiatric treatments. His academic experience spans the key components of neuroscience clinical trial methodology: conduct of proof-of-concept (PoC) biomarker-based clinical trials in surrogate populations, testing of repurposed compounds, development of stratification and efficacy biomarkers and creation of infrastructure for large-scale stratified recruitment into neuroscience experimental medicine studies and clinical trials. Clinically, he has focused on a practice focused on the assessment and management of patients with neuropsychiatric presentations in acute medical settings.
Advertizing
